| Dr William L Rives, MD | |
|
1 Childrens Pl, Div Ped Hospitalist Med, Saint Louis, MO 63110-1002 | |
| (314) 454-2076 | |
| (314) 747-8953 |
| Full Name | Dr William L Rives |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 1 Childrens Pl, Saint Louis, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003832312 | NPI | - | NPPES |
| 204016505 | Medicaid | MO |
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194765685 PECOS PAC ID: 9830008770 Enrollment ID: O20040607000287 |
News Archive
In most transplant centers, the kidneys of very young deceased donors are transplanted together into one patient. According to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN), a single kidney from a very young deceased donor maintains the health of an adult with kidney failure.
The enzyme that 'loads up' fat-carrying particles in the liver before they are transported around the body has been identified for the first time by scientists at the University of Warwick.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
By turning skin cells into brain neurons, researchers at the Icahn School of Medicine at Mount Sinai have identified that certain tiny molecules aiding in gene expression, known as microRNAs (miRNAs), are under-expressed in the brains of the 14 schizophrenia patients they studied. Their findings, published online today in the journal Cell Reports, show that one of these molecules, a miRNA known as miR-9, is a risk factor that controls the activity of hundreds of genes.
In a recent analysis, people with epilepsy were seven-fold more likely to have reported experiencing discrimination due to health problems than the general population. This risk was greater than other chronic health problems such as diabetes, asthma and migraines.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William L Rives, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 454-2076 | Dr William L Rives, MD 1 Childrens Pl, Div Ped Hospitalist Med, Saint Louis, MO 63110-1002 Ph: (314) 454-2076 |
News Archive
In most transplant centers, the kidneys of very young deceased donors are transplanted together into one patient. According to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN), a single kidney from a very young deceased donor maintains the health of an adult with kidney failure.
The enzyme that 'loads up' fat-carrying particles in the liver before they are transported around the body has been identified for the first time by scientists at the University of Warwick.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
By turning skin cells into brain neurons, researchers at the Icahn School of Medicine at Mount Sinai have identified that certain tiny molecules aiding in gene expression, known as microRNAs (miRNAs), are under-expressed in the brains of the 14 schizophrenia patients they studied. Their findings, published online today in the journal Cell Reports, show that one of these molecules, a miRNA known as miR-9, is a risk factor that controls the activity of hundreds of genes.
In a recent analysis, people with epilepsy were seven-fold more likely to have reported experiencing discrimination due to health problems than the general population. This risk was greater than other chronic health problems such as diabetes, asthma and migraines.
› Verified 3 days ago
Dr. Robert Shi-heng Young, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Dr. Sumera Younus, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3009 N Ballas Rd Ste 387c, Saint Louis, MO 63131 Phone: 314-996-5900 | |
Dr. James Matthew Freer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Dr. Rachel Hannah Bardowell, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Jabon L Ellis, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1201 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-257-8222 Fax: 915-742-2653 | |
Dr. Patrick Hodge White, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Dr. Jeffrey B Friesen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 |